Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications, and therapeutic potentials

World J Gastrointest Pharmacol Ther. 2024 Nov 5;15(6):98146. doi: 10.4292/wjgpt.v15.i6.98146.

Abstract

With the rising prevalence of chronic liver diseases worldwide, there exists a need to diversify our artillery to incorporate a plethora of diagnostic and therapeutic methods to combat this disease. Currently, the most common causes of liver disease are non-alcoholic fatty liver disease, hepatitis, and alcoholic liver disease. Some of these chronic diseases have the potential to transform into hepatocellular carcinoma with advancing fibrosis. In this review, we analyse the relationship between the gut and liver and their significance in liver disease. This two-way relationship has interesting effects on each other in liver diseases. The gut microbiota, through its metabolites, influences the metabolism in numerous ways. Careful manipulation of its composition can lead to the discovery of numerous therapeutic potentials that can be applied in the treatment of various liver diseases. Numerous cohort studies with a pan-omics approach are required to understand the association between the gut microbiome and hepatic disease progression through which we can identify effective ways to deal with this issue.

Keywords: Dysbiosis; Fecal microbiota transplantation; Gut-liver axis; Liver disease; Precision medicine; Probiotics.

Publication types

  • Review